期刊文献+

T2DM合并慢性肾脏疾病患者血清MCP-1变化及其临床意义 被引量:4

下载PDF
导出
摘要 目的探讨血清单核细胞趋化蛋白-1(MCP-1)在2型糖尿病(T2DM)合并慢性肾脏疾病(CKD)发生发展中的作用。方法将179例T2DM患者根据24h尿清蛋白排泄率(UAER)分为正常清蛋白尿组(NA组)65例、微量清蛋白尿组(MA组)61例及临床清蛋白尿组(CP组)53例。另外选取健康对照者50名为对照组(NC组)。检测研究对象血清MCP-1、收缩压(SBP)、舒张压(DBP)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、肌酐(Cr)、尿素氮(BUN)、糖化血红蛋白(HbA1c);葡萄糖氧化酶法测定空腹血糖(FPG);化学发光法测定空腹胰岛素(FINS)临床指标水平,比较各组间差异。结果 NA组、MA组及CP组血清MCP-1均高于NC组(P<0.05),且各组间比较差异有统计学意义(F=128 8.0,P<0.01)。Pearson相关分析显示,血清MCP-1与SBP、DBP、BUN、Cr、UAER、TG、TC、LDL-C、HbA1c、FPG、FINS及稳态胰岛素抵抗指数(HOMA-IR)呈正相关(r=0.612、0.167、0.652、0.632、0.784、0.458、0.349、0.363、0.621、0.538、0.511、0.557,P<0.05);与HDL-C和胰岛素敏感指数(ISI)呈负相关(r=-0.338、-0.633,P<0.05)。多元线性回归分析显示,UAER、ISI、SBP、HOMA-IR、病程、HDL-C、TG是T2DM患者MCP-1的独立相关因素。结论血清MCP-1随尿蛋白严重程度而逐渐升高,可作为T2DM合并CKD诊断和病情判定的重要参考指标。
出处 《重庆医学》 CAS 北大核心 2015年第27期3827-3829,共3页 Chongqing medicine
  • 相关文献

参考文献9

二级参考文献45

  • 1Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly : the cardiovascular health study[ J]. Diabetes,2001 ;50:2384-9.
  • 2Sehlondorff D, Nelson PJ, Luckow B ,et al. Chemokines and renal disease [J]. Kid Int,1997 ;51:610-21.
  • 3Matsui T, Yamagishi S, Ueda S, et al. Telmisartan, an angiotensin Ⅱ type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoatractant protein-1 expression in mesangial cells through down regulation of receptor for AGEs via peroxisome proliferatoractivated receptor-gamma activation[J]. J Int Med Res,2007 ;35:482-9.
  • 4Zoja C, Donadelli R, Colleoni S, et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB aefivation [J]. Kidney Int, 1998 ;53 : 1608-15.
  • 5Kamanna VS, Pai R, Roh DD, et al. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation [ J ]. J Lab Invest, 1996;74:1067-79.
  • 6Ruiz-ortega M, Bustos C, Hemandez-presa MA,et al. Angiotensin Ⅱ participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis[J]. Immunology, 1998 ;6:430-9.
  • 7Aso Y, Okumura K, Inoue T, et al. Result of blood inflammatory markers are associated more strongly with toe-brachial index than with ankle-brachial index in patients with type 2 diabetes [J]. Diabetes Care,2004; 27:1381-6.
  • 8Chow F, Ozols E, Paterson N,et al Macrophages in mouse type 2 diabetic nephropathy correlation with diabetic state and progression renal injury [ J]. Kidney Int ,2004 ;65 : 116-28.
  • 9Wolf G,Ziyadeh FN. The role of angiotensin Ⅱ in diabetic nephropathy: emphasis on nonhemodynamic mechanisms[J]. Am J Kidney Dis, 1997; 29 : 153-63.
  • 10Calandra T, Bemhagen J, Metz CN, et al. MIF as a glucocorticoid induced modulator of cytokine production[ J]. Nature, 1995 ;377:68-71.

共引文献36

同被引文献37

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部